Loading clinical trials...
Loading clinical trials...
A Phase II Study of the Effect of ACE Inhibitors on Pro-Angiogenic Hormones in Cancer Patients With Hypertension
Conditions
Interventions
lisinopril
losartan potassium
+3 more
Locations
1
United States
Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States
Start Date
February 1, 2011
Primary Completion Date
December 1, 2013
Completion Date
April 1, 2014
Last Updated
August 28, 2018
NCT02417740
NCT07073820
NCT07480265
NCT06876233
NCT06062394
NCT06899815
Lead Sponsor
Wake Forest University Health Sciences
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions